Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
----------------
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 2)
SpectRx, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
847635109
(CUSIP Number)
David Musket
c/o ProMed Management Inc.
125 Cambridgepark Drive
Cambridge, Massachusetts 02140
(617) 441-8800
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
February 6, 2008
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box |X|.
Note: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits. See Rule
13d-7 for other parties to whom copies are to be sent.
- ----------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 847635109
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
ProMed Partners, L.P.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
1,256,550
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
1,256,550
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,256,550
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.35%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 847635109
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
ProMed Offshore Fund, Ltd.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
195,160
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 195,160
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
195,160
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.30%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 847635109
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
ProMed Offshore Fund II, Ltd.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
100,000
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 100,000
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
100,000
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
.66%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 847635109
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
ProMed Management, Inc.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
AF, WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
1,256,550
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 1,256,550
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,256,550
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.35%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IA, CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 847635109
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
ProMed Asset Management, LLC
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
AF, WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
295,160
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 295,160
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
295,160
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.96%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IA, CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 847635109
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
David B. Musket
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
AF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
198,222
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 1,551,710
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 198,222
WITH ----------------------------------
-------------------------------
10 SHARED DISPOSITIVE POWER
1,551,710
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,749,932
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.63%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 847635109
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Barry Kurokawa
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
AF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
48,222
-----------------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 1,551,710
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 48,222
WITH -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
1,551,710
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,599,932
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.63%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 847635109
Item 1. Security and Issuer.
The name of the issuer is SpectRx, Inc., a Delaware corporation (the
"Issuer"). The address of the Issuer's offices is 4955 Avalon Ridge Parkway,
Suite 300, Norcross, Georgia 30071. This Schedule 13D relates to the Issuer's
Common Stock.
Item 2. Identify and Background.
(a-c,f) This Schedule 13D is being filed jointly by (i) ProMed Partners, L.P. a
Delaware limited partnership ("ProMed I"), (ii) ProMed Offshore Fund, Ltd., a
British Virgin Islands corporation ("ProMed Offshore"), (iii) ProMed Offshore
Fund II, Ltd., a British Virgin Islands corporation ("ProMed Offshore Fund II,
Ltd"), (iv) ProMed Management, Inc., a Massachusetts corporation ("ProMed
Management, Inc."), (v) ProMed Asset Management, LLC, a Massachusetts limited
liability company, (vi) David B. Musket, a United States citizen and (vii)
Barry Kurokawa, a United States citizen (collectively, the "Reporting Persons").
The principal business address of (i) ProMed I, ProMed Management, ProMed
Asset Management, David B. Musket and Barry Kurokawa is 125 Cambridge Park
Drive, Cambridge, Massachusetts 02140 and ProMed Offshore Ltd., and ProMed
Offshore Fund II, Ltd. is C/O Trident Trust Company (B.V.I.) Limited, Trident
Chambers, Wickham Cay, Post Office Box 146, Road Town, Tortola, British Virgin
Islands.
David B. Musket and Barry Kurokawa are the principals of ProMed
Management, Inc. which is an investment management firm that serves as the
investment manager to private investment funds, including ProMed I and ProMed II
and ProMed.
(d) Neither of David B. Musket nor Barry Kurokawa has, during the last five
years, been convicted in any criminal proceeding (excluding traffic violations
or similar misdemeanors).
(e) None of the Reporting Persons has, during the last five years, been a party
to a civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a judgment,
decree or final order enjoining future violations of, or prohibiting or
mandating activities subject to, Federal or state securities laws or finding any
violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration.
The funds for the purchase of the Shares came from the working capital of
ProMed I, ProMed II, ProMed Offshore Fund, Ltd. and ProMed Offshore Fund II,
Ltd. over which David B. Musket and Barry Kurokawa, through their role at ProMed
Management, Inc. exercise investment discretion.
No borrowed funds were used to purchase the Shares, other than any
borrowed funds used for working capital purposes (including certain leverage
arrangements) in the ordinary course of business.
Item 4. Purpose of Transaction.
The Reporting Persons previously filed a Schedule 13D relating to the Common
Stock of the Issuer. This filing reflects additional shares that the Series A
Preferred ("Preferred") can be converted into as a result of anti-dilution
provisions that were triggered by the Amended and Restated Loan Agreement which
was described in the Issuer's Form 8-K filed on March 12, 2007. The Reporting
Persons continue to be active in discussions concerning the Issuer's business
strategy, size and business strategy, size and composition of the Board of
Directors, management structure and compensation. The Reporting Persons may seek
to actively enlist other shareholders to facilitate such changes.
Item 5. Interest in Securities of the Issuer.
(a-e) The aforementioned shares were acquired for investment purposes in open
markets and private transactions. As of date date hereof, (i) ProMed I may be
deemed to be the beneficial owner of 1,256,550 Shares or 8.35% of the Shares of
the Issuer, (ii) ProMed Offshore Funds, Ltd. may be deemed to be the beneficial
owner of 195,160 Shares or 1.30% of the Shares of the Issuer (iii) ProMed
Offshore Fund II, Ltd. may be deemed to be the beneficial owner of 100,000 or
..66% of the Shares of the Issuer, (iv) ProMed Management, Inc. may be deemed to
be the beneficial owner of 295,160 or 1.96% of the Shares of the Issuer, (v)
ProMed Asset Management, LLC may be deemed to be the beneficial owner of
1,256,550 or 8.35% of the Shares of the Issuer, (vi) David B. Musket may be
deemed to be the beneficial owner of 198,222 or 1.32% of the Shares of the
Issuer, (vii) Barry Kurokawa may be deemed to be the beneficial owner of 48,222
or .32% of the Shares of the Issuer, based upon the 13,253,424 Shares
outstanding as of December 31, 2007.
As of the date hereof, (i) ProMed I has the shared power to vote or direct
the vote of 1,256,550 Shares to which this filing relates, (ii) ProMed Offshore
Fund, Ltd. has the shared power to vote or direct the vote of 195,160 Shares to
which this filing relates, (iii) ProMed Offshore Fund II, Ltd. has the shared
power to vote or direct the vote of 100,000 Shares to which this filing relates,
(iv) ProMed Management, Inc. has the shared power to vote or direct the vote of
295,160 Shares to which this filing relates, (v) ProMed Asset Management, LLC
has the shared power to vote or direct the vote of 1,256,550 Shares to which
this filing relates, (vi) David B. Musket has the sole power to vote or direct
the vote of 198,222 Shares and the shared power to vote or direct the vote of
1,551,710 Shares to which this filing relates and (vii) Barry Kurokawa has the
sole power to vote or direct the vote of 48,222 Shares and the shared power to
vote or direct the vote of 1,551,710 Shares to which this filing relates.
As of the date hereof, (i) ProMed I has the shared power to dispose or
direct the disposition of 1,256,550 Shares to which this filing relates,
(ii) ProMed Offshore Fund, Ltd. has the
shared power to dispose or direct the disposition of 195,160 Shares to which
this filing relates, (iii) ProMed Offshore Fund II, Ltd. has the shared power to
dispose or direct the disposition of 100,000 Shares to which this filing
relates, (iv) ProMed Management, Inc. has the shared power to dispose or direct
the disposition of 295,160 Shares to which this filing relates, (v) ProMed
Asset Management has the shared power to dispose or direct the disposition of
1,256,550 Shares to which this filing relates, (vi) David B. Musket has the
shared power to dispose or direct the disposition of 1,551,710 Shares to which
this filing relates and (vii) Barry Kurokawa has the shared power to dispose or
direct the disposition of 1,551,710 Shares to which this filing relates.
The aforementioned Shares were acquired for investment purposes. Each of
David B. Musket and Barry Kurokawa, either in an individual capacity or on
behalf of the private investment vehicles over which they have investment
discretion through their role at ProMed Management, may acquire additional
Shares, dispose of all or some of these Shares from time to time, in each case
in open markets or private transactions, block sales or purchases otherwise, or
may continue to hold the Shares.
During the past 60 days, the Reporting Persons have effected those
transactions listed in Exhibit A with respect to the Shares of the Issuer.
The Reporting Persons specifically disclaim beneficial ownership in the
Shares reported herein except to the extent of their pecuniary interest therein.
Item 6. Contracts, Arrangement, Understandings or Relationships with Respect to
Securities of the Issuer.
N/A
Item 7. Material to be Filed as Exhibits.
N/A
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 6, 2008
- -----------------------
(Date)
/s/ David B. Musket*
-----------------------------------
David B. Musket
/s/ Barry Kurokawa*
-----------------------------------
Barry Kurokawa
ProMed Partners, L.P.*
By: ProMed Asset Management, LLC,
its general partner
By: DBM Corporate Consulting Group,
Ltd., a Managing Member
By: /s/ David B. Musket
Name: David B. Musket
Title: President
ProMed Offshore Fund, Ltd.*
By: /s/ David B. Musket
-------------------------------
Name: David B. Musket
Title: Director
ProMed Offshore Fund II, Ltd.
By: /s/ David B. Musket
-------------------------------
Name: David B. Musket
Title: Director
ProMed Management, Inc.*
By: /s/ David B. Musket
-------------------------------
Name: David B. Musket
Title: President
ProMed Asset Management, LLC
By: /s/ David B. Musket
-------------------------------
Name: David B. Musket
Title: Managing Member
AGREEMENT
The undersigned agree that this Schedule 13D dated March 12, 2007 relating
to the Common Stock of SpectRx, Inc. shall be filed on behalf of the
undersigned.
/s/ David B. Musket*
-----------------------------------
David B. Musket
/s/ Barry Kurokawa*
-----------------------------------
Barry Kurokawa
ProMed Partners, L.P.*
By: ProMed Asset Management, LLC,
its general partner
By: DBM Corporate Consulting Group,
Ltd., a Managing Member
By: /s/ David B. Musket
-------------------------------
Name: David B. Musket
Title: President
ProMed Offshore Fund, Ltd.*
By: /s/ David B. Musket
-------------------------------
Name: David B. Musket
Title: Director
ProMed Offshore Fund II, Ltd.
By: /s/ David B. Musket
-------------------------------
Name: David B. Musket
Title: Director
ProMed Management, Inc.*
By: /s/ David B. Musket
-------------------------------
Name: David B. Musket
Title: President
ProMed Asset Management, LLC
By: /s/ David B. Musket
-------------------------------
Name: David B. Musket
Title: Managing Member
February 6, 2008